- Home
- SLNO vs FBK Comparison
SLNO vs FBK Comparison
Compare SLNO & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- FBK
- Stock Information
- Founded
- SLNO 1999
- FBK 1906
- Country
- SLNO United States
- FBK United States
- Employees
- SLNO N/A
- FBK N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FBK Major Banks
- Sector
- SLNO Health Care
- FBK Finance
- Exchange
- SLNO Nasdaq
- FBK Nasdaq
- Market Cap
- SLNO 1.9B
- FBK 2.2B
- IPO Year
- SLNO 2014
- FBK 2016
- Fundamental
- Price
- SLNO $53.89
- FBK $48.14
- Analyst Decision
- SLNO Strong Buy
- FBK Buy
- Analyst Count
- SLNO 7
- FBK 7
- Target Price
- SLNO $68.71
- FBK $43.25
- AVG Volume (30 Days)
- SLNO 803.1K
- FBK 124.2K
- Earning Date
- SLNO 11-05-2024
- FBK 10-15-2024
- Dividend Yield
- SLNO N/A
- FBK 1.42%
- EPS Growth
- SLNO N/A
- FBK N/A
- EPS
- SLNO N/A
- FBK 2.30
- Revenue
- SLNO N/A
- FBK $436,397,000.00
- Revenue This Year
- SLNO N/A
- FBK N/A
- Revenue Next Year
- SLNO N/A
- FBK $7.44
- P/E Ratio
- SLNO N/A
- FBK $20.85
- Revenue Growth
- SLNO N/A
- FBK N/A
- 52 Week Low
- SLNO $21.30
- FBK $27.75
- 52 Week High
- SLNO $56.81
- FBK $51.40
- Technical
- Relative Strength Index (RSI)
- SLNO 57.97
- FBK 53.82
- Support Level
- SLNO $53.02
- FBK $45.82
- Resistance Level
- SLNO $54.86
- FBK $51.40
- Average True Range (ATR)
- SLNO 2.13
- FBK 1.38
- MACD
- SLNO 0.23
- FBK 0.28
- Stochastic Oscillator
- SLNO 68.82
- FBK 50.25
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.